Skip Navigation


Hum. Reprod. Advance Access originally published online on August 7, 2006
Human Reproduction 2006 21(12):3241-3245; doi:10.1093/humrep/del301
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/12/3241    most recent
del301v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Basille, C.
Right arrow Articles by Morice, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basille, C.
Right arrow Articles by Morice, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Impact of gonadotrophins and steroid hormones on tumour cells derived from borderline ovarian tumours

Claire Basille1, François Olivennes2, Josyane Le Calvez3, Nadine Beron-Gaillard3, Geri Meduri4, Catherine Lhommé5, Pierre Duvillard6, Jean Benard3 and Philippe Morice1,7

1 Departement de Chirurgie, Institut Gustave Roussy, Villejuif 2 Hopital Cochin, Paris 3 Departement de Biologie et de Pathologie Médicale, Institut Gustave Roussy, Villejuif 4 INSERM Unité 693, Le Kremlin-Bicêtre 5 Departement de Medecine, Institut Gustave Roussy, Villejuif, and 6 Departement de Pathologie, Institut Gustave Roussy, Villejuif, France

7 To whom correspondence should be addressed at: Service de Chirurgie, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif Cedex, France. E-mail: morice{at}igr.fr

BACKGROUND: Conservative surgery is currently proposed for young patients with borderline ovarian tumours (BOT). For those experiencing infertility, the question of medically assisted procreation is raised. We have evaluated in vitro the proliferation of cultured BOT cells in response to FSH or estradiol (E2). METHODS: Primary cell cultures were prepared from BOT. The presence of FSH and E2 receptors was evaluated by immunochemistry. Cultures in vitro were stimulated with FSH (40 and 200 mUI/ml) or E2 (300 and 2000 pg/ml) for 96 h and proliferation was evaluated with the WST-1 test. RESULTS: Four primary cultures were obtained that expressed FSH and E2 receptors to different extents. Growth was generally similar to controls when treated with either FSH or E2 although 300 pg/ml E2 caused a significant inhibitory effect on cell proliferation (P = 0.035). CONCLUSION: No stimulatory effect of FSH or E2 on cultured BOT cells was found, despite the presence of receptors. Although preliminary, these results suggest that gonadotrophins and E2 could be used in patients experiencing infertility after conservative surgery.

Key words: borderline ovarian tumours/estradiol/FSH/gonadotrophin/infertility


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.